SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-1.04%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$541M
AUM Growth
+$541M
(-11%)
Cap. Flow
-$24.3M
Cap. Flow
% of AUM
-4.49%
Top 10 Holdings %
Top 10 Hldgs %
32.22%
Holding
125
New
17
Increased
28
Reduced
37
Closed
22
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$8.28M |
| 2 |
Annexon
ANNX
|
$6.38M |
| 3 |
Ormat Technologies
ORA
|
$5.35M |
| 4 |
Eledon Pharmaceuticals
ELDN
|
$5.17M |
| 5 |
SolarEdge
SEDG
|
$5.1M |
Top Sells
| 1 |
Apple
AAPL
|
$14.2M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$12.4M |
| 3 |
Amazon
AMZN
|
$9.43M |
| 4 |
SentinelOne
S
|
$6.62M |
| 5 |
Nice
NICE
|
$6.09M |
Sector Composition
| 1 | Healthcare | 74.91% |
| 2 | Technology | 16.21% |
| 3 | Communication Services | 3.96% |
| 4 | Consumer Discretionary | 2.54% |
| 5 | Utilities | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teva Pharmaceuticals
TEVA
$21.1B
| $34.6M | 6.25% | 1,569,181 -561,035 | -26% | -$12.4M |
|
2
BridgeBio Pharma
BBIO
$9.89B
| $24.8M | 4.49% | 905,279 +62,635 | +7% | +$1.72M |
|
3
Sanofi
SNY
$121B
| $18.5M | 3.35% | 384,515 -25,000 | -6% | -$1.21M |
|
4
Syndax Pharmaceuticals
SNDX
$1.41B
| $18.3M | 3.3% | 1,381,241 +346,395 | +33% | +$4.58M |
|
5
AstraZeneca
AZN
$248B
| $14.7M | 2.67% | 225,060 +35,000 | +18% | +$2.29M |
|
|
6
Amazon
AMZN
$2.44T
| $13.7M | 2.48% | 62,607 -43,000 | -41% | -$9.43M |
|
7
Nova
NVMI
$7.74B
| $13.4M | 2.43% | 68,146 +16,186 | +31% | +$3.19M |
|
8
Meta Platforms (Facebook)
META
$1.86T
| $12.3M | 2.22% | 21,001 -8,315 | -28% | -$4.87M |
|
9
Sarepta Therapeutics
SRPT
$1.78B
| $12M | 2.17% | 98,921 -26,925 | -21% | -$3.27M |
|
10
Celldex Therapeutics
CLDX
$1.47B
| $12M | 2.17% | 474,103 +55,000 | +13% | +$1.39M |
|
|
11
Eledon Pharmaceuticals
ELDN
$155M
| $10.5M | 1.9% | 2,551,619 +1,254,298 | +97% | +$5.17M |
|
12
Eli Lilly
LLY
$657B
| $10.2M | 1.84% | 13,190 | – | – |
|
13
Johnson & Johnson
JNJ
$427B
| $10.1M | 1.83% | 69,831 | – | – |
|
14
Ultragenyx Pharmaceutical
RARE
$2.89B
| $9.62M | 1.74% | 228,776 +33,427 | +17% | +$1.41M |
|
15
Microsoft
MSFT
$3.77T
| $9.41M | 1.7% | 22,327 -11,100 | -33% | -$4.68M |
|
16
Marvell Technology
MRVL
$54.2B
| $8.68M | 1.57% | 78,611 -9,000 | -10% | -$994K |
|
17
Tower Semiconductor
TSEM
$6.58B
| $8.56M | 1.55% | 166,149 -43,292 | -21% | -$2.23M |
|
18
Novo Nordisk
NVO
$251B
| $8.44M | 1.53% | 98,080 +20,000 | +26% | +$1.72M |
|
19
WIX.com
WIX
$7.85B
| $8.42M | 1.52% | 39,253 +5,000 | +15% | +$1.07M |
|
|
20
Alphabet (Google) Class C
GOOG
$2.58T
| $8.28M | 1.5% | +43,500 | New | +$8.28M |
|
21
Pharvaris
PHVS
$1.39B
| $7.44M | 1.35% | 388,183 -51,109 | -12% | -$980K |
|
|
22
Nice
NICE
$8.73B
| $7.22M | 1.3% | 42,500 -35,861 | -46% | -$6.09M |
|
23
Cytokinetics
CYTK
$4.23B
| $7.2M | 1.3% | 153,021 -72,000 | -32% | -$3.39M |
|
24
Praxis Precision Medicines
PRAX
$958M
| $7.05M | 1.27% | 91,583 -60,724 | -40% | -$4.67M |
|
25
Check Point Software Technologies
CHKP
$20.7B
| $6.65M | 1.2% | 35,635 -4,580 | -11% | -$855K |
|